Amaç:
Yüksek profilli dental implant yerleştirilmesinde yönlendirilmiş doku
augmentasyonunu geliştirmek için plateletten zengin fibrin (PRF) ve rifamisin
uygulamasının potansiyelinin değerlendirilmesi.
Materyal
ve metod: İki mm’lik koronal kısmı kemik dışında kalan
dental implantlar kubbe şeklinde sert kaplayıcı titanyum membran ile kapatılmış
ve membranın içi demineralize dondurularak kurutulmuş kemik allogrefti (DFDBA)+salin
(7 tavşan), DFDBA+rifamisin (8 tavşan) veya DFDBA+PRF (8 tavşan) ile
doldurulmuştur.
Bulgular:
Kemik implant kontağı (KİK) salin grubunda 58.43±1.92%, rifamisin grubunda
68.34±20.37% ve PRF grubunda 80.70±2.55% olarak tespit edilmiştir. Sırasıyla
yeni kemik oluşum yüzdesi de 36.90±0.94, 45.26±0.60 ve 51.82±0.82 olarak
bulunmuştur.
Sonuç:
Hem PRF hem de rifamisinin yönlendirilmiş doku augmentasyonunu geliştirici
potansiyeli olduğu ve yüksek profilli dental implant uygulamalarında sert
kaplayıcı titanyum membran altında DFDBA + PRF veya DFDBA + rifamisin
kullanılmasının hem KİK değerini hem de yeni kemik oluşum yüzdesini
artırabileceği görülmüştür.
Kemik Takviyesi Trombosit bakımından zengin fibrin rifamisin Yüksek profilli diş implantları
Objective: To evaluate the
potential of platelet-rich fibrin (PRF) and rifamycin to enhance guided bone
augmentation with simultaneous high-profile dental implant placement in a
rabbit tibia model.
Materials and Methods: Dental implants
protruding 2 mm were covered with dome-shaped stiff occlusive titanium barriers
filled with demineralized freeze-dried bone allograft (DFDBA)+saline (7
rabbits), DFDBA + rifamycin (8 rabbits), or DFDB +PRF (8 rabbits). After 4
weeks, the animals were sacrificed, and undecalcified histomorphometric
examination with toluidine blue staining was performed.
Results: The
bone-to-implant contact (BIC) was 58.43 ± 1.92% in the saline group, 68.3 ±20.37%
in the rifamycin group, and 80.70±2.55% in the PRF group, and the percentage of
new bone formation was 36.90 ± 0.94%, 45.26±0.60%, and 51.82±0.82%,
respectively. Conclusions: Both PRF and rifamycin have potential to enhance
GBA, and using DFDBA + PRF or DFDBA+rifamycin beneath a stiff occlusive
titanium barrier next to a high-profile implant may enhance both BIC and new
bone formation.
Keywords: Guided bone augmentation, platelet-rich fibrin, rifamycin, allograft,
high-profile dental implants
Guided bone augmentation platelet-rich fibrin rifamycin allograft high-profile dental implants
Konular | Sağlık Kurumları Yönetimi |
---|---|
Bölüm | Original Research Articles |
Yazarlar | |
Yayımlanma Tarihi | 12 Mayıs 2017 |
Gönderilme Tarihi | 20 Nisan 2017 |
Yayımlandığı Sayı | Yıl 2017Cilt: 20 Sayı: 1 |
Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.
CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.
Frequency: Four times a year (March, June, September, and December)
IMPORTANT NOTICE
All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.
Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.